
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145727010.1021/acsomega.7b00626ArticleAmmonium Acetate-Promoted One-Pot Tandem Aldol Condensation/Aza-Addition
Reactions: Synthesis of 2,3,6,7-Tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones Zhang Zhiguo *†§Gao Xiaolong †Wan Yameng †Huang Yuanyuan †Huang Guoqing ‡Zhang Guisheng *†† Henan
Key laboratory of Organic Functional Molecule and Drug Innovation,
Collaborative Innovation Center of Henan Province for Green Manufacturing
of Fine Chemicals, Key Laboratory of Green Chemical Media and Reactions,
Ministry of Education, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China‡ Handan
Purification Equipment Research Institute, Handan, Hebei 056027, China§ Jilin
Province Key Laboratory of Organic Functional Molecular Design &
Synthesis, Northeast Normal University, Jilin, Changchun 130024, China* E-mail: zhangzg@htu.edu.cn. Fax: (+86)-373-332-5250 (Z.Z.).* E-mail: zgs6668@yahoo.com (G.Z.).17 10 2017 31 10 2017 2 10 6844 6851 18 05 2017 03 10 2017 Copyright © 2017 American Chemical Society2017American Chemical SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

An
efficient tandem intermolecular one-pot aldol condensation/aza-addition
reaction of 2-methyl-3-carbamoylpyrroles and aldehydes was developed
for the synthesis of 2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones. The reaction proceeded
using only 3.0 equiv of ammonium acetate promoter in green solvent
poly(ethylene glycol)-400 at 100 °C to afford a series of pyrrolo[3,2-c]pyridinone derivatives in good to excellent yields.

document-id-old-9ao7b00626document-id-new-14ao-2017-006263ccc-price
==== Body
1 Introduction
Pyrrolo[3,2-c]pyridinones are important nitrogen-containing
fused heterocyclic compounds that act as essential structures in the
skeletons of numerous biologically active molecules, such as TAK-4411 and PH-089 (Figure 1).2 These molecules
possess a wide variety of bioactivities, including DP receptor antagonists,
CK1γ inhibitors, CB2 agonists, Cdc7 kinase inhibitors,
PLK1 inhibitors, ATP competition, MK2 inhibitors, and NAMPT inhibitors.3 Pyrrolo[3,2-c]pyridinones are
also valuable intermediates in organic synthesis.4 The two strategies most commonly used to access this type
of fused heterocycle are cyclizations of preprepared functionalized
pyrroles or pyridine derivatives via multistep procedures.5 Other efficient methods to prepare these compounds
from simple materials via multicomponent domino reactions have also
been established.6 In 2004, Xi et al.6a reported the development of a multicomponent
domino reaction for the preparation of pyrrolo[3,2-c]pyridines, which involved the reaction of Si-tethered diynes with
three different organonitriles in the presence of a zirconocene species.
Despite these advances, the development of a one-pot approach to the
construction of pyrrolo[3,2-c]pyridines in an environmentally
benign and economically viable manner and with a broad substrate scope
remains largely unrealized. Herein, we report the synthesis of 2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones via the one-pot domino aldol condensation/aza-addition reaction
of functionalized pyrroles and aldehydes using only 3.0 equiv of ammonium
acetate promoter in green solvent poly(ethylene glycol)-400 (PEG-400). 1   2  

Figure 1 Structures of TAK-441 and PH-089.

In 2014, we developed an iron-catalyzed vinylogous
aldol condensation
of Biginelli reaction products with aryl aldehydes for the synthesis
of potential bioactive (E)-6-arylvinyl-dihydropyrimidin-2(1H)-ones.7 These materials were
shown to be valuable synthetic precursors to druglike pyrido[4,3-d]pyrimidine derivatives via the intramolecular addition
reaction of alkenes with the amide group at the 5-position in the
dihydropyrimidin-2(1H)-ones. In 2015, we developed
a facile and efficient one-pot approach to the synthesis of 1H-pyrrolo[3,2-c]pyridin-4(5H)-one derivatives via the domino ring-opening/cyclization/aza-addition
reaction of doubly activated cyclopropanes with amines, which did
not require a catalyst or additives (eq 1).6b Our interest in the
construction of this type of heterocycle has continued with the new
strategy reported herein. Ammonium acetate, a mild weak-acid weak-base
salt, is widely used in organic synthesis and has frequently served
as an important ammonia source in the synthesis of various heterocyclic
scaffolds,8 a base for effective Knoevenagel
condensations,9 an acid in a variant of
the Pummerer reaction,10 and to facilitate
dissolution.11 Combining these applications
with our recent work on heterocycle synthesis,12 especially regarding pyrrole derivatization,13 we deduced that readily available 2-methyl-3-carbamoylpyrroles
(1)14 and aldehydes (2) would undergo condensation followed by an intramolecular
aza-addition reaction to afford fused heterocycles 1H-pyrrolo[3,2-c]pyridin-4(5H)-ones
in the presence of ammonium acetate (eq 2).15

2 Results
and Discussion
With this reaction in mind, N-(4-chlorophenyl)-2-methyl-1-(p-tolyl)-4,5-dihydro-1H-pyrrole-3-carboxamide
(1a) was selected as a model substrate13e and reacted with benzaldehyde (2a) to optimize
the reaction conditions. The results of these optimization experiments
are summarized in Table 1. Compound 3a was isolated as a white solid in 92% yield
when 1a and 2a were treated with 5 equiv
of ammonium acetate in PEG-400 (3 mL) under N2 atmosphere
at 100 °C for 4 h (Table 1, entry 1).16 Further investigation
showed that 3 equiv of ammonium acetate was adequate for this transformation
(Table 1, entry 2).
However, the yield of 3a dropped dramatically when the
reaction was performed in the presence of 1 equiv of ammonium acetate
for 5 h (Table 1, entry
3). Decreasing or increasing the reaction temperature was not helpful
to improve the yield of 3a (Table 1, entries 4 and 5). Similar results were
observed under an O2 atmosphere, open-air conditions, and
even with the addition of oxidant DDQ under N2 atmosphere
(Table 1, entries 6–8).
Five different ammonium-containing salts, namely, NH4F,
FeSO4(NH4)2SO4·6H2O, NH4VO3, NH4HCO3, and (NH4)2SO4, were evaluated
in the reaction. The experiments indicated that these ammonium salts
showed a slightly lower catalytic efficiency than that of ammonium
acetate (Table 1, entries
9–13). Significantly lower yields of 3a (40–80%)
were obtained when dimethyl sulfoxide (DMSO), ethanol (EtOH), 1-butyl-3-methylimidazolium
tetrafluoroborate ([BMIM]BF4), and 1-butyl-3-methylimidazolium
hexafluorophosphate ([BMIM]PF6) were used as solvents instead
of PEG-400 (Table 1, entries 14–17).

Table 1 Survey of Reaction
Conditionsa
entry	ammonium
salt (equiv)	solvent	time/h	3a/%	
1	NH4OAc (5.0)	PEG-400	4	88	
2	NH4OAc (3.0)	PEG-400	5	90	
3	NH4OAc (1.0)	PEG-400	5	85	
4	NH4OAc (3.0)/80 °C	PEG-400	5	83	
5	NH4OAc (3.0)/120 °C	PEG-400	4	87	
6	NH4OAc (3.0)/Air	PEG-400	3	70	
7	NH4OAc (3.0)/O2	PEG-400	5	80	
8	NH4OAc (3.0)/DDQ (2.2)	PEG-400	6	0b	
9	NH4F (3.0)	PEG-400	5	83	
10	FeSO4(NH4)2SO4·6H2O (3.0)	PEG-400	5	80	
11	NH4VO3 (3.0)	PEG-400	5	78	
12	NH4HCO3 (3.0)	PEG-400	5	86	
13	(NH4)2SO4 (3.0)	PEG-400	5	85	
14	NH4OAc (3.0)	DMSO	5	80	
15	NH4OAc (3.0)	EtOH	5	40	
16	NH4OAc (3.0)	[BMIM]BF4	5	70	
17	NH4OAc (3.0)	[BMIM]PF6	5	65	
a Unless otherwise indicated, all
reactions were carried out in a sealed tube with 1a (0.5
mmol) and 2a (0.55 mmol) in solvent (3 mL) at 100 °C
under N2.

b 1,5-Bis(4-chlorophenyl)-6-phenyl-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one (4a) was isolated in 90% yield.

With optimized reaction conditions in hand (Table 1, entry 2), this tandem aldol/aza-addition
reaction was extended to an array of functionalized pyrroles 1 and aldehydes 2 to explore the scope and limitations
of the reaction. The results are summarized in Table 2. The impact of the R1 substituent
on the amide moiety of pyrroles 1 on the outcome of this
tandem reaction was evaluated. The results indicated that starting
materials 1a–e, which bear electron-withdrawing
groups (EWG) or electron-donating groups (EDG) on the aryl moiety,
reacted efficiently with 2a to afford corresponding products 3a–f in 72–93% yields, except for 3e, which was isolated in a slightly lower yield (65%). R1 groups with aliphatic substituents were not tested due to
the limited availability of preparation methods for these types of
starting materials. However, a variety of R2 substituents
were tested, with substrates bearing chloro- or methoxyl- groups at
the para-, meta-, or ortho-positions of the benzene ring found to be well tolerated
(3g–l). In addition to phenyl derivatives
at R2, we also examined aliphatic substrates. The transformation
proceeded well using benzyl- and cyclohexyl-substituted substrates 1m and 1n, affording desired compounds 3m and 3n, respectively, in excellent yields.

Table 2 Extension of the Reaction Scopea
a Unless otherwise indicated, all
reactions were carried out with 1 (0.5 mmol), 2 (0.55 mmol), and NH4OAc (3.0 equiv) in PEG-400 (3 mL)
at 100 °C under an N2 atmosphere in a sealed tube.

The scope of the methodology
with respect to the aldehyde was also
evaluated in reactions with pyrrole derivative 1a. The
results showed that the electronic nature and position (ortho-, meta-,
or para-) of the substituents (−OMe, −Cl, and −CO2Et) on the phenyl ring had little impact on the yield of the
corresponding fused cyclic compounds 3o–x (79–88%). Similarly, cyclohexanecarbaldehyde, cyclopropanecarbaldehyde,
and heterocyclic formaldehydes, such as 2-thenaldehyde and 2-pyridinecarboxaldehyde,
were well tolerated in the reaction, affording the desired products 3y–b′ in 67–75% yields.

During this research, we failed to isolate any intermediates from
the reaction mixture. However, liquid chromatography–mass spectrometry
analysis of the reaction mixtures showed molecular ion peaks with
almost the same m/z value (415.3036) as that of the
product 3a (415.2387).17 It
suggested that species A might be a reaction intermediate.
Accordingly, a plausible reaction mechanism was proposed, as shown
in Scheme 1. First,
compounds 1 and 2 undergo aldol condensation
to afford intermediate A, assisted by ammonium acetate.9a,18 Subsequently, intermediate A undergoes an intramolecular
nucleophilic aza-addition reaction to afford the final product 3.6b,19 However, another plausible mechanism
involving an ammonium acetate-assisted 6π-azaelectrocyclization
could not be excluded.20

Scheme 1 Proposed Mechanism
3 Conclusions
In summary, a facile and efficient one-pot domino reaction has
been developed for the synthesis of 2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-ones
from 2-methyl-3-carbamoylpyrroles and aldehydes in the presence of
ammonium acetate (3.0 equiv) in green solvent PEG-400 at 100 °C.
This high atom economy protocol uses readily available starting materials,
affords good to excellent yields, and has a broad substrate scope.

4 Experimental Section
4.1 General Remarks
All reactions were
carried out at 100 °C, unless otherwise indicated. All other
reagents were purchased from commercial sources and used without further
treatment, unless otherwise indicated. Starting material 1 was prepared by following previous methods.14 Petroleum ether (PE) used here refers to the 60–90 °C
boiling point fraction of petroleum. Ethyl acetate is abbreviated
as EA. 1H NMR and 13C NMR spectra were recorded
on Bruker Avance/600 (1H: 600 MHz, 13C: 150
MHz at 25 °C) or Bruker Avance/400 (1H: 400 MHz, 13C: 100 MHz at 25 °C) and tetramethylsilane as the internal
standard. Data are represented as follows: chemical shift, integration,
multiplicity (br = broad, s = singlet, d = doublet, dd = double doublet,
t = triplet, q = quartet, and m = multiplet), and coupling constants
in Hertz (Hz). All high-resolution mass spectra (HRMS) were measured
on a mass spectrometer by using electrospray ionization orthogonal
acceleration time-of-flight (ESI-oa-TOF), and the purity of all samples
used for HRMS (>95%) was confirmed by 1H NMR and 13C NMR spectroscopic analysis. Melting points were measured
on a melting
point apparatus equipped with a thermometer and were uncorrected.
All reactions were monitored by thin-layer chromatography (TLC) with
GF254 silica gel-coated plates, and in general, it was designated
as the end of the reaction when the starting material 1 was consumed 1 h later. Flash chromatography was carried out on
SiO2 (silica gel 200–300 mesh).

4.2 Typical Experimental Procedure for the Synthesis
of 3 (3a as an Example)
To a sealed
tube with a branch pipe (25 mL) were added N-(4-chlorophenyl)-2-methyl-1-(p-tolyl)-4,5-dihydro-1H-pyrrole-3-carboxamide 1a (163 mg, 0.5 mmol), benzaldehyde 2a (58.3
mg, 0.55 mmol), and NH4OAc (115.6 mg, 1.5 mmol) and filled
with nitrogen through the branch pipe by standard Schlenk techniques;
then, the mixture was well stirred for 5 h in PEG-400 (3 mL) at 100
°C (the whole process was closely monitored by TLC). After the
completion of the reaction, the reaction was quenched by water (10
mL) and the mixture was extracted with dichloromethane (3 × 5
mL). The combined organic layers were dried over Na2SO4. After filtration and concentration, the crude product was
purified by flash column chromatography with EA/PE to afford 3a (191 mg, 90%).

4.2.1 5-(4-Chlorophenyl)-6-phenyl-1-(p-tolyl)-2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (3a)
The product was isolated by flash chromatography (eluent: EA/PE
= 3/10) as a white solid (191 mg, 90%): mp 181–182 °C; 1H NMR (400 MHz, CDCl3) δ 7.27–7.16
(m, 5H), 7.13 (d, J = 8.8 Hz, 2H), 7.06 (m, 4H),
6.73 (d, J = 8.0 Hz, 2H), 5.11–5.04 (m, 1H),
3.96–3.88 (m, 2H), 3.3–3.30 (dd, J =
16.8, 5.6 Hz, 1H), 3.08–3.00 (m, 1H), 2.95–2.86 (m,
1H), 2.81 (d, J = 14.4 Hz, 1H), 2.25 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.9, 140.9, 140.5,
138.4, 134.2, 130.6, 130.1, 128.9, 128.7, 127.9, 126.9, 126.7, 121.2,
62.5, 54.3, 32.4, 25.6, 20.9. HRMS (ESI), m/z calcd
for C26H23ClN2ONa ([M + Na]+) 437.1391, found: 437.1391.

4.2.2 5-(3-Chlorophenyl)-6-phenyl-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3b)
The product was
isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (178.0 mg, 86%): mp 73–76 °C; 1H NMR
(400 MHz, CDCl3) δ 7.33–7.26 (m, 6H), 7.13
(t, J = 8 Hz, 3H), 7.06 (t, J =
9.2 Hz, 2H), 6.79 (d, J = 8.4 Hz, 2H), 5.18–5.17
(m, 1H), 4.03–3.89 (m, 2H), 3.40 (dd, J =
16.8, 6.4 Hz, 1H), 3.03 (t, J = 10.6 Hz, 1H), 2.99–2.92
(m, 1H), 2.88 (d, J = 15.6 Hz, 1H), 2.33 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.6, 143.7, 140.5,
138.5, 133.7, 133.5, 129.8, 129.2, 128.6, 127.6, 126.4, 125.5, 124.8,
123.1, 120.8, 62.1, 53.7, 32.2, 25.4, 20.7. HRMS (ESI), m/z calcd for C26H23ClN2ONa ([M + Na]+) 437.1391, found: 437.1398.

4.2.3 5-(2-Chlorophenyl)-6-phenyl-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3c)
The product was
isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (176.0 mg, 85%): mp 72–75 °C; 1H NMR
(400 MHz, CDCl3) δ 7.45 (dd, J =
8.0, 1.6 Hz, 1H), 7.36–7.26 (m, 5H), 7.19 (dd, J = 7.6, 2.0 Hz, 1H), 7.16–7.12 (m, 4H), 6.85 (d, J = 8.4 Hz, 2H), 5.09 (dd, J = 6.4, 4 Hz, 1H), 4.10–3.95
(m, 2H), 3.54 (dd, J = 16.8, 6.8 Hz, 1H), 3.10–2.98
(m, 2H), 2.94–2.89 (m, 1H), 2.34 (s, 3H). 13C NMR
(100 MHz, CDCl3) δ 165.5, 153.7, 140.5, 139.3, 139.0,
133.0, 132.7, 131.9, 130.0, 129.7, 128.4, 128.1, 127.6, 127.1, 127.0,
120.6, 105.0, 61.6, 53.4, 31.9, 25.5, 20.7. HRMS (ESI), m/z calcd for C26H23ClN2ONa ([M + Na]+) 437.1391, found: 437.1402.

4.2.4 Ethyl
4-(4-Oxo-6-phenyl-1-(p-tolyl)-1,2,3,4,6,7-hexahydro-5H-pyrrolo[3,2-c]pyridin-5-yl)benzoate (3d)
The product
was isolated by flash chromatography (eluent: EA/PE = 2/10) as a white
solid (210.2 mg, 93%): mp 143–145 °C; 1H NMR
(400 MHz, CDCl3) δ 7.84 (d, J =
8.8 Hz, 2H), 7.24–7.20 (m, 6H), 7.18 (s, 1H), 7.04 (d, J = 8.4 Hz, 2H), 6.70 (d, J = 8.4 Hz, 2H),
5.18 (dd, J = 6.4, 2.4 Hz, 1H), 4.28–4.23
(m, 2H), 3.94–3.84 (m, 2H), 3.35 (dd, J =
16.8, 6.0 Hz, 1H), 3.03–2.94 (m, 1H), 2.89–2.80 (m,
2H), 2.25 (s, 3H), 1.29 (t, J = 7.0 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ 166.3, 165.5, 146.7,
140.5, 138.4, 133.6, 129.8, 128.7, 127.6, 126.4, 125.8, 123.7, 120.8,
61.7, 60.7, 53.7, 32.2, 25.4, 20.7, 14.3. HRMS (ESI), m/z calcd for C29H28N2O3 ([M + Na]+) 475.1992, found: 475.2002.

4.2.5 5-(4-Methoxyphenyl)-6-phenyl-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3e)
The product was
isolated by flash chromatography (eluent: EA/PE = 1/5) as a white
solid (133.3 mg, 65%): mp 146–147 °C; 1H NMR
(400 MHz, CDCl3) δ 7.29 (d, J =
7.2 Hz, 2H), 7.21 (d, J = 7.2 Hz, 2H), 7.13 (d, J = 7.6 Hz, 2H), 7.08–7.02 (m, 3H), 6.84–6.81
(m, 2H), 6.76 (d, J = 8.4 Hz, 2H), 5.11 (s, 1H),
4.11–4.07 (m, 2H), 3.73 (s, 3H), 3.50–3.43 (m, 2H),
3.15 (s, 1H), 3.91–2.86 (m, 1H), 2.31 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.7, 153.5, 141.1, 140.7,
138.7, 133.3, 129.9, 129.8, 128.6, 128.4, 127.5, 126.52, 126.49, 120.7,
105.5, 62.1, 53.6, 32.3, 25.4, 20.7. HRMS (ESI), m/z calcd for C27H27N2O2 ([M + H]+) 411.2067, found: 411.2074.

4.2.6 6-Phenyl-5-(pyridin-3-yl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3f)
The product was
isolated by flash chromatography (eluent: EA/PE =2/10) as a yellow
solid (137 mg, 72%): mp 60–62 °C; 1H NMR (600
MHz, CDCl3) δ 8.45 (s, 1H), 8.27 (s, 1H), 7.56 (d, J = 7.8 Hz, 1H), 7.28–7.24 (m, 6H), 7.15 (t, J = 5.7 Hz 1H), 7.10 (d, J = 7.2 Hz, 2H),
6.77 (d, J = 7.2 Hz, 2H), 5.17 (s, 1H), 3.98–3.92
(m, 2H), 3.37 (dd, J1 = 16.5 Hz, J2 = 5.1 Hz, 1H), 3.04–2.98 (m, 1H), 2.95–2.86
(m, 2H), 2.30 (s, 3H). 13C NMR (150 MHz, CDCl3) δ 165.8, 154.0, 146.4, 145.5, 140.4, 139.1, 138.6, 133.6,
132.6, 129.9, 128.8, 127.8, 126.6, 123.0, 121.0, 105.2, 77.3, 77.1,
76.9, 62.0, 53.7, 32.4, 25.5, 20.8. HRMS (ESI), m/z calcd for C25H24N3O ([M + H]+) 382.1914, found: 382.1932.

4.2.7 1,5-Bis(4-chlorophenyl)-6-phenyl-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3g)
The product was isolated by flash chromatography (eluent:
EA/PE = 3/10) as a white solid (188.8 mg, 87%): mp 203–205
°C; 1H NMR (400 MHz, CDCl3) δ 7.35–7.27
(m, 2H), 7.27–7.22 (m, 5H), 7.19–7.17 (m, 2H), 7.13–7.10
(m, 2H), 6.76 (d, J = 8.8 Hz, 2H), 5.15 (dd, J = 6.4, 3.2 Hz, 1H), 3.99–3.85 (m, 2H), 3.41 (dd, J = 16.4, 6.4 Hz, 1H), 3.05–2.90 (m, 2H), 2.86 (d, J = 19.2 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 165.5, 152.2, 140.8, 140.5, 139.8, 130.2, 129.3,
128.7, 128.5, 128.2, 127.7, 126.5, 126.5, 121.1, 107.2, 62.1, 53.2,
32.4, 25.5. HRMS (ESI), m/z calcd for C25H20Cl2N2ONa ([M + Na]+) 457.0845, found: 457.0864.

4.2.8 1-(3-Chlorophenyl)-5-(4-chlorophenyl)-6-phenyl-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3h)
The product was isolated by flash chromatography (eluent:
EA/PE = 1/20) as a white solid (184.9 mg, 85%): mp 192–193
°C; 1H NMR (400 MHz, CDCl3) δ 7.30–7.26
(m, 2H), 7.25 (d, J = 7.2 Hz, 3H), 7.20–7.16
(m, 3H), 7.11 (d, J = 8.8 Hz, 2H), 6.99 (d, J = 7.2 Hz, 1H), 6.79 (s, 1H), 6.72 (d, J = 8.0 Hz, 1H), 5.14 (d, J = 3.2 Hz, 1H), 3.97–3.87
(m, 2H), 3.45–3.41 (m, 1H), 3.01–2.94 (m, 1H), 2.89
(d, J = 15.2 Hz, 2H). 13C NMR (100 MHz,
CDCl3) δ 165.4, 151.9, 142.4, 140.8, 140.4, 135.0,
130.4, 130.2, 128.8, 128.5, 127.7, 126.6, 126.5, 122.8, 119.7, 117.8,
107.8, 62.2, 53.1, 32.5, 25.5. HRMS (ESI), m/z calcd for C25H20Cl2N2ONa ([M + Na]+) 457.0845, found: 457.0869.

4.2.9 1-(2-Chlorophenyl)-5-(4-chlorophenyl)-6-phenyl-2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (3i)
The product was isolated by flash
chromatography (eluent: EA/PE = 1/20) as a white solid (176.2 mg,
81%): mp 187–190 °C; 1H NMR (400 MHz, CDCl3) δ 7.39 (d, J = 8.0 Hz, 1H), 7.30–7.26
(m, 6H), 7.19–7.13 (m, 6H), 5.09 (m, 1H), 4.03 (s, 1H), 3.70
(s, 1H), 3.09–3.03 (m, 2H), 3.02–2.09 (m, 1H), 2.49
(d, J = 12.0 Hz, 1H).13C NMR (100 MHz,
CDCl3) δ 165.7, 155.5, 141.3, 140.9, 132.7, 130.7,
130.1, 128.7, 128.6, 128.4, 128.2, 127.8, 127.6, 126.8, 126.6, 62.2,
54.9, 31.5, 26.2. HRMS (ESI), m/z calcd for C25H20Cl2N2ONa ([M + Na]+) 457.0845, found: 457.0876.

4.2.10 5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-6-phenyl-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3j)
The product was isolated by flash chromatography (eluent:
EA/PE = 1/10) as a white solid (184.9 mg, 86%): mp 134–137
°C; 1H NMR (400 MHz, CDCl3) δ 7.30–7.27
(m, 3H), 7.24–7.22 (m, 2H), 7.18 (d, J = 8.8
Hz, 2H), 7.11 (d, J = 8.8 Hz, 2H), 6.84–6.73
(m, 4H), 5.11 (dd, J = 6.0, 3.2 Hz, 1H), 3.92 (t, J = 9.6 Hz, 2H), 3.78 (s, 3H), 3.29 (dd, J = 16.8, 6.4 Hz, 1H), 3.09–3.01 (m, 1H), 2.97–2.89
(m, 1H), 2.76 (d, J = 14.4 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 165.8, 156.7, 141.0, 140.6,
134.2, 130.2, 128.7, 128.5, 127.7, 126.64, 126.57, 123.4, 114.6, 62.2,
55.6, 54.8, 32.1, 25.6. HRMS (ESI), m/z calcd for
C26H24ClN2O2 ([M + H]+) 431.1521, found: 431.1531.

4.2.11 5-(4-Chlorophenyl)-1-(3-methoxyphenyl)-6-phenyl-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3k)
The product was isolated by flash chromatography (eluent:
EA/PE = 1/10) as a white solid (187.1 mg, 87%): mp 138–140
°C; 1H NMR (400 MHz, CDCl3) δ 7.30
(d, J = 5.6 Hz, 2H), 7.30–7.28 (m, 3H), 7.23
(d, J = 8.4 Hz, 3H), 7.17 (d, J =
8.8 Hz, 2H), 6.64 (dd, J = 8.4, 2.0 Hz, 1H), 6.50
(d, J = 8.0 Hz, 1H), 6.43 (s, 1H), 5.19–5.17
(m, 1H), 4.07–3.94 (m, 2H), 3.81 (s, 3H), 3.55–3.46
(m, 1H), 3.11–3.05 (m, 1H), 3.00–2.97 (m, 2H). 13C NMR (100 MHz, CDCl3) δ 165.6, 160.3, 152.9,
142.4, 140.9, 140.6, 130.2, 130.0, 128.7, 128.5, 127.6, 126.6, 112.7,
108.1, 106.6, 62.3, 55.3, 53.3, 32.5, 25.5. HRMS (ESI), m/z calcd for C26H24ClN2O2 ([M + H]+) 431.1521, found: 431.1543.

4.2.12 5-(4-Chlorophenyl)-1-(2-methoxyphenyl)-6-phenyl-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3l)
The product was isolated by flash chromatography (eluent:
EA/PE = 1/10) as a white solid (182.8 mg, 85%): mp 147–149
°C; 1H NMR (400 MHz, CDCl3) δ 7.29–7.26
(m, 1H), 7.22 (t, J = 3.8 Hz, 4H), 7.16–7.11
(m, 3H), 7.08–7.06 (m, 2H), 6.82 (t, J = 8.0
Hz, 3H), 5.00 (dd, J = 6.4, 2.8 Hz, 1H), 3.92–3.86
(m, 1H), 3.74–3.69 (m, 1H), 3.50 (s, 3H), 3.04–2.86
(m, 3H), 2.46 (d, J = 16.4 Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 165.5, 160.2, 153.2, 142.2,
140.8, 140.4, 130.1, 129.9, 128.6, 128.4, 127.6, 126.53, 126.46, 112.6,
108.1, 106.5, 62.2, 55.2, 53.3, 32.4, 25.4. HRMS (ESI), m/z calcd for C26H24ClN2O2 ([M + H]+) 431.1521, found: 431.1552.

4.2.13 1-Benzyl-5-(4-chlorophenyl)-6-phenyl-2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (3m)
The product was isolated by flash
chromatography (eluent: EA/PE = 1/10) as a white solid (165.6 mg,
80%): mp 89–91 °C; 1H NMR (400 MHz, CDCl3) δ 7.37–7.29 (m, 5H), 7.22–7.17 (m, 3H),
7.17–7.13 (m, 4H), 6.87–6.83 (m, 2H), 5.16–5.14
(m, 1H), 4.27 (d, J = 16.0 Hz, 1H), 4.10 (d, J = 16.0 Hz, 1H), 3.47–3.39 (m, 1H), 3.35–3.18
(m, 2H), 2.93–2.77 (m, 2H), 2.73 (d, J = 16.0
Hz, 1H). 13C NMR (100 MHz, CDCl3) δ 165.5,
156.9, 141.5, 141.1, 136.3, 129.4, 128.6, 128.2, 127.43, 127.36, 126.8,
126.4, 126.2, 101.3, 61.7, 51.3, 50.2, 31.0, 25.3. HRMS (ESI), m/z calcd for C26H24ClN2O ([M + H]+) 415.1572, found: 415.1576.

4.2.14 5-(4-Chlorophenyl)-1-cyclohexyl-6-phenyl-2,3,6,7-tetrahydro-1H-pyrrolo[3,2-c]pyridin-4(5H)-one (3n)
The product was isolated by flash
chromatography (eluent: EA/PE = 1/10) as a white solid (164.4 mg,
81%): mp 137–140 °C; 1H NMR (400 MHz, CDCl3) δ 7.26–7.18 (m, 5H), 7.11–7.05 (m, 4H),
5.06 (dd, J = 6.8, 3.6 Hz, 1H), 3.51–3.32
(m, 2H), 3.11–3.01 (m, 2H), 2.83–2.69 (m, 2H), 1.77
(d, J = 12.8 Hz, 1H), 1.66 (dd, J = 15.2, 2.0 Hz, 1H), 1.58 (d, J = 12.8 Hz, 1H),
1.41–1.35 (m, 1H), 1.30–1.20 (m, 4H), 1.17–1.11
(m, 1H), 1.05–0.92 (m, 1H). 13C NMR (100 MHz, CDCl3) δ 165.4, 157.0, 141.5, 141.2, 129.1, 128.4, 128.0,
127.2, 126.3, 126.2, 100.5, 61.5, 54.7, 46.5, 31.0, 30.5, 25.3, 25.1,
24.8. HRMS (ESI), m/z calcd for C25H27ClN2ONa ([M + Na]+) 429.1704, found:
429.1700.

4.2.15 5,6-Bis(4-Chlorophenyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3o)
The product was
isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (195.3 mg, 87%): mp 151–152 °C; 1H NMR
(400 MHz, CDCl3) δ 7.26–7.24 (m, 2H), 7.18
(t, J = 7.6 Hz, 4H), 7.11 (dd, J = 7.6, 3.6 Hz, 4H), 6.78 (d, J = 8.4 Hz, 2H), 5.11–5.10
(m, 1H), 4.04–3.88 (m, 2H), 3.38 (dd, J =
16.8, 6.4 Hz, 1H), 3.03 (t, J = 11.6 Hz, 1H), 2.96–2.92
(m, 1H), 2.79 (d, J = 16.4 Hz, 1H), 2.31 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.5, 140.7, 139.0,
138.2, 133.4, 130.3, 129.9, 128.9, 128.5, 127.9, 126.5, 120.9, 61.6,
53.8, 32.1, 25.4, 20.7. HRMS (ESI), m/z calcd C26H22Cl2N2O2Na
for ([M + Na]+) 471.1001, found: 471.1002.

4.2.16 6-(3-Chlorophenyl)-5-(4-chlorophenyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3p)
The product was
isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (190.8 mg, 85%): mp 174–177 °C; 1H NMR
(400 MHz, CDCl3) δ 7.45–7.43 (m, 1H), 7.34–7.32
(m, 1H), 7.23–7.21 (m, 2H), 7.19 (d, J = 8.8
Hz, 2H), 7.11–7.07 (m, 4H), 6.75 (d, J = 8.4
Hz, 2H), 5.52 (dd, J = 6.8, 2.4 Hz, 1H), 4.04–3.88
(m, 2H), 3.38 (dd, J = 17.2, 7.2 Hz, 1H), 3.10–2.97
(m, 2H), 2.92 (dd, J = 10.0, 2.4 Hz, 1H), 2.30 (s,
3H). 13C NMR (100 MHz, CDCl3) δ 165.9,
140.9, 138.6, 137.6, 133.2, 131.7, 130.1, 129.9, 129.1, 128.6, 128.5,
127.1, 126.3, 120.5, 105.1, 59.3, 53.5, 29.8, 25.4, 20.7. HRMS (ESI), m/z calcd for C26H22Cl2N2ONa ([M + Na]+) 471.1001, found: 471.1024.

4.2.17 6-(2-Chlorophenyl)-5-(4-chlorophenyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3q)
The product was
isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (181.8 mg, 81%): mp 140–141 °C; 1H NMR
(400 MHz, CDCl3) δ 7.45–7.43 (m, 1H), 7.33
(dd, J = 4.8, 2.0 Hz, 1H), 7.24–7.21 (m, 2H),
7.19 (d, J = 8.4 Hz, 2H), 7.10–7.08 (m, 4H),
6.75 (d, J = 8.0 Hz, 2H), 5.52 (d, J = 4.8 Hz, 1H), 4.03–3.90 (m, 2H), 3.38 (dd, J = 16.4, 6.0 Hz, 1H), 3.08–2.89 (m, 3H), 2.30 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.9, 140.9, 138.6,
137.6, 133.3, 131.72, 130.2, 130.1, 129.8, 129.1, 128.7, 128.5, 127.1,
126.3, 120.5, 59.3, 53.6, 29.8, 25.4, 20.7. HRMS (ESI), m/z calcd for C26H22Cl2N2ONa ([M + Na]+) 471.1001, found: 471.1020.

4.2.18 Methyl 4-(5-(4-Chlorophenyl)-4-oxo-1-(p-tolyl)-2,3,4,5,6,7-hexahydro-1H-pyrrolo[3,2-c]pyridin-6-yl)benzoate (3r)
The product
was isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (203.0 mg, 86%): mp 175–177 °C; 1H NMR
(400 MHz, CDCl3) δ 7.96 (d, J =
8.0 Hz, 2H), 7.31 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.8 Hz, 2H), 7.10 (d, J = 8.0 Hz, 4H),
6.76 (d, J = 8.0 Hz, 2H), 5.18 (s, 1H), 3.99–3.91
(m, 2H), 3.89 (s, 3H), 3.40 (dd, J = 16.0, 5.2 Hz,
1H), 3.04 (t, J = 10.4 Hz, 1H), 2.97–2.93
(m, 1H), 2.83 (d, J = 15.6 Hz, 1H), 2.30 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 166.5, 165.5, 145.6,
140.6, 138.1, 134.1, 130.5, 130.0, 129.9, 129.7, 128.6 126.6, 126.5,
121.1, 62.04, 54.0, 52.1, 32.0, 25.4, 20.7. HRMS (ESI), m/z calcd for C28H25ClN2O3Na ([M + Na]+) 495.1446, found: 495.1443.

4.2.19 5-(4-Chlorophenyl)-1,6-di-p-tolyl-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3s)
The product was
isolated by flash chromatography (eluent: EA/PE = 3/10) as a white
solid (188.3 mg, 88%): mp 147–149 °C; 1H NMR
(400 MHz, CDCl3) δ 7.45–7.43 (m, 1H), 7.33
(dd, J = 6.4, 4.8 Hz, 1H), 7.23–7.17 (m, 4H),
7.10–7.08 (m, 4H), 6.74 (d, J = 8.4 Hz, 2H),
5.52 (dd, J = 6.8, 2.4 Hz, 1H), 4.02–3.87
(m, 2H), 3.40–3.34 (m, 1H), 3.30–2.89 (m, 3H), 2.30
(s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.7,
140.7, 138.2, 137.4, 137.1, 133.9, 130.3, 129.9, 129.4, 128.5, 126.7,
126.4, 120.9, 62.0, 54.0, 32.4, 25.4, 21.0, 20.7. HRMS (ESI), m/z calcd for C27H25ClN2ONa ([M + Na]+) 451.1548, found: 451.1550.

4.2.20 5-(4-Chlorophenyl)-6-(m-tolyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3t)
The product was
isolated by flash chromatography (eluent:
EA/PE =3/10) as a white solid (186.2 mg, 87%): mp 160–161 °C; 1H NMR (400 MHz, CDCl3) δ 7.18–7.15
(m, 3H), 7.14–7.09 (m, 4H), 7.06–7.01 (m, 3H), 6.78
(d, J = 8.0 Hz, 2H), 5.10 (dd, J = 6.0, 2.8 Hz, 1H), 4.03–3.88 (m, 2H), 3.39 (dd, J = 16.4, 6.0 Hz, 1H), 3.04 (t, J = 10.6
Hz, 1H), 3.98–2.89 (m, 1H), 2.87 (d, J = 15.2
Hz, 1H), 2.30 (d, J = 2.8 Hz, 6H). 13C
NMR (100 MHz, CDCl3) δ 165.5, 154.0, 140.7, 139.1,
138.3, 133.7, 133.4, 130.3, 129.9, 128.8, 128.5, 127.9, 126.5, 120.9,
61.6, 53.7, 53.4, 32.1, 25.4, 20.7. HRMS (ESI), m/z calcd for C27H25ClN2ONa ([M + Na]+) 451.1548, found: 451.1558.

4.2.21 5-(4-Chlorophenyl)-6-(o-tolyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3u)
The product was isolated by flash chromatography (eluent:
EA/PE =3/10) as a white solid (177.6 mg, 83%): mp 164–165 °C; 1H NMR (400 MHz, CDCl3) δ 7.18–7.15
(m, 3H), 7.14–7.09 (m, 4H), 7.06–7.01 (m, 3H), 6.78
(d, J = 8.4 Hz, 2H), 5.10 (dd, J = 6.0, 3.2 Hz, 1H), 4.05–3.88 (m, 2H), 3.38 (dd, J = 16.8, 6.4 Hz, 1H), 3.06–2.93 (m, 2H), 2.86 (d, J = 17.2 Hz, 1H), 2.30 (d, J = 2.4 Hz,
6H). 13C NMR (100 MHz, CDCl3) δ 165.7,
140.9, 140.5, 138.5 138.3, 133.4, 130.0, 129.8, 128.5, 128.4, 127.1,
126.5, 123.6, 62.1, 53.7, 32.3, 25.4, 21.5, 20.7. HRMS (ESI), m/z calcd for C27H25ClN2ONa ([M + Na]+) 451.1548, found: 451.1558.

4.2.22 5-(4-Chlorophenyl)-6-(4-methoxyphenyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3v)
The product was
isolated by flash chromatography (eluent: EA/PE =3/10) as a white
solid (184.3 mg, 83%): mp 154–156 °C; 1H NMR
(400 MHz, CDCl3) δ 7.17 (t, J =
64 Hz, 3H), 7.13–0.08 (m, 5H), 6.81–6.75 (m, 4H), 5.07
(dd, J = 6.0, 3.2 Hz, 1H), 4.01–3.87 (m, 2H),
3.77 (s, 3H), 3.33 (dd, J = 16.8, 6.4 Hz, 1H), 3.04–2.87
(m, 2H), 2.82 (dd, J = 16.8, 2.4 Hz, 1H), 2.30 (s,
3H). 13C NMR (100 MHz, CDCl3) δ 165.7,
158.9, 153.7, 141.1, 138.7, 133.3, 132.6, 130.0, 129.8, 128.4, 127.7,
126.6, 120.7, 113.9, 100.0, 61.7, 55.2, 53.6, 32.5, 25.5, 20.7. HRMS
(ESI), m/z calcd for C27H25ClN2O2Na ([M + Na]+) 467.1497, found:
467.1516.

4.2.23 5-(4-Chlorophenyl)-6-(3-methoxyphenyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3w)
The product was
isolated by flash chromatography (eluent: EA/PE =3/10) as a white
solid (179.8 mg, 81%): mp 160–162 °C; 1H NMR
(400 MHz, CDCl3) δ 7.17 (d, J =
8.8 Hz, 2H), 7.14 (s, 2H), 7.11–7.07 (m, 6H), 6.77 (d, J = 8.0 Hz, 2H), 5.10 (dd, J = 6.0, 3.2
Hz, 1H), 4.02–3.88 (m, 2H), 3.36 (dd, J =
16.8, 6.4 Hz, 1H), 3.05–2.92 (m, 2H), 2.85 (d, J = 16.4 Hz, 1H), 2.31 (s, 6H). 13C NMR (100 MHz, CDCl3) δ 165.7, 159.7, 142.2, 140.8, 138.4, 133.6, 130.2,
129.8, 129.7, 128.4, 126.7, 120.8, 118.6, 112.6, 112.5, 62.2, 55.2,
53.8, 32.2, 25.4, 20.7. HRMS (ESI), m/z calcd for
C27H25ClN2O2Na ([M + Na]+) 467.1497, found: 467.1490.

4.2.24 5-(4-Chlorophenyl)-6-(2-methoxyphenyl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3x)
The product was
isolated by flash chromatography (eluent: EA/PE =3/10) as a white
solid (175.4 mg, 79%): mp 183–186 °C; 1H NMR
(400 MHz, CDCl3) δ 7.30 (d, J =
7.6 Hz, 1H), 7.24–7.22 (m, 1H), 7.20–7.11 (m, 4H), 7.09
(d, J = 8.4 Hz, 2H), 6.91 (t, J =
7.5 Hz, 1H), 6.84 (d, J = 8.2 Hz, 1H), 6.74 (d, J = 8.4 Hz, 2H), 5.47 (dd, J = 6.8, 2.0
Hz, 1H), 4.02–3.85 (m, 2H), 3.77 (s, 3H), 3.31 (dd, J = 16.8, 6.8 Hz, 1H), 3.08–2.89 (m, 3H), 2.30 (s,
3H). 13C NMR (100 MHz, CDCl3) δ 166.1,
155.7, 141.0, 138.7, 133.0, 129.9, 129.7, 128.7, 128.3, 127.8, 127.7,
126.3, 120.5, 120.4, 110.5, 57.0, 55.2, 53.6, 29.9, 25.3, 20.7. HRMS
(ESI), m/z calcd for C27H26ClN2O2 ([M + H]+) 445.1677, found:
445.1677.

4.2.25 5-(4-Chlorophenyl)-6-cyclohexyl-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3y)
The product was
isolated by flash chromatography (eluent: EA/PE =2/10) as a white
solid (140.7 mg, 67%): mp 153–156 °C; 1H NMR (400 MHz,
CDCl3) δ 7.29 (s, 1H), 7.24–7.20 (m, 3H),
7.15 (d, J = 8.0 Hz, 2H), 6.88 (d, J = 8.0 Hz, 2H), 6.26 (s, 1H), 6.18 (s, 1H), 5.13 (s, 1H), 4.15–3.94
(m, 2H), 3.23 (d, J = 14.8 Hz, 1H), 3.08–2.86
(m, 3H), 2.33 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.2, 141.2, 138.5, 131.0, 130.0, 129.4, 129.1, 128.72,
128.67, 121.0, 64.0, 54.1, 41.1, 30.3, 29.2, 26.1, 26.0, 25.5, 20.8.
HRMS (ESI), m/z calcd for C26H29ClN2ONa ([M + Na]+) 443.1861, found: 443.1883.

4.2.26 5-(4-Chlorophenyl)-6-cyclopropyl-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3z)
The product was
isolated by flash chromatography (eluent: EA/PE =2/10) as a yellow
oil (142 mg, 75%); 1H NMR (400 MHz, CDCl3) δ
7.62 (dd, J1 = 7.8 Hz, J2 = 1.4 Hz, 1H), 7.55 (dd, J1 = 7.8 Hz, J2 = 1.4 Hz, 1H), 7.43–7.35
(m, 2H), 7.30 (d, J = 8.4 Hz, 2H), 7.06 (d, J = 8.4 Hz, 2H), 4.29–4.01 (m, 3H), 3.26 (dd, J1 = 16.4 Hz, J2 =
6.0 Hz, 1H), 3.14–3.03 (m, 3H), 2.88 (dd, J1 = 16.4 Hz, J2 = 4.8 Hz,
1H), 2.47 (s, 3H), 0.50–0.37 (m, 2H), 0.05–0.00 (m,
2H). 13C NMR (150 MHz, CDCl3) δ 165.5,
155.1, 139.4, 139.2, 133.2, 132.8, 129.8, 128.1, 126.8, 120.4, 104.5,
63.1, 53.3, 30.1, 25.6, 20.7, 14.8, 5.3, 1.8. HRMS (ESI), m/z calcd for C23H24ClN2O ([M + H]+) 379.1572, found: 379.1588.

4.2.27 5-(4-Chlorophenyl)-6-(thiophen-2-yl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3a′)
The product
was isolated by flash chromatography (eluent: EA/PE =3/10) as a white
solid (153.3 mg, 73%): mp 143–146 °C; 1H NMR
(400 MHz, CDCl3) δ 7.23 (d, J =
8.8 Hz, 2H), 7.17 (s, 1H), 7.15–7.13 (m, 3H), 7.12 (s, 1H),
6.87 (s, 1H), 6.85–6.83 (m, 2H), 6.79 (d, J = 3.2 Hz, 1H), 5.30 (dd, J = 6.0, 2.0 Hz, 1H),
4.18–4.07 (m, 1H), 3.98–3.91 (m, 1H), 3.51–3.38
(m 1H), 3.07–2.92 (m, 2H), 2.88 (d, J = 16.4
Hz, 1H), 2.31 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 164.8, 143.6, 140.6, 138.4, 133.6, 130.8, 129.8, 128.6,
127.5, 126.2, 125.8, 124.9, 120.8, 59.2, 53.7, 32.2, 25.4, 20.7. HRMS
(ESI), m/z calcd for C24H21ClN2OSNa ([M + Na]+) 443.0955, found: 443.0941.

4.2.28 5-(4-Chlorophenyl)-6-(pyridin-2-yl)-1-(p-tolyl)-1,2,3,5,6,7-hexahydro-4H-pyrrolo[3,2-c]pyridin-4-one (3b′)
The product
was isolated by flash chromatography (eluent: EA/PE =2/10) as a white
solid (145.3 mg, 70%): mp 164–165 °C; 1H NMR
(400 MHz, CDCl3) δ 8.54 (s, 1H), 7.76 (s, 1H), 7.48
(s, 1H), 7.27 (s, 1H), 7.19 (d, J = 9.6 Hz, 4H),
7.11 (d, J = 5.6 Hz, 2H), 6.80 (d, J = 6.8 Hz, 2H), 5.36 (s, 1H), 3.91 (s, 2H), 3.40 (s, 2H), 2.98 (s,
1H), 2.84 (s, 1H), 2.30 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 165.2, 159.5, 154.1, 140.8, 138.4, 133.5, 129.9,
129.4, 128.6, 128.4, 125.6, 122.9, 122.0, 120.8, 120.6, 105.4, 62.6,
53.5, 30.3, 25.4, 20.7. HRMS (ESI), m/z calcd for
C25H22ClN3O ([M + Na]+) 438.1344, found: 438.1335.

Supporting Information Available
The Supporting
Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.7b00626.1H
and 13C NMR spectra for all
compounds (PDF)

Crystallographic data (CIF)



Supplementary Material
ao7b00626_si_001.pdf

 ao7b00626_si_002.cif

 The authors
declare no competing financial interest.

Acknowledgments
We are thankful to the NSFC (21272057, 21372065, 21772032,
and U1604285), Young Backbone Teachers Fund of Henan (2014GGJS-049),
Key Project of Henan Educational Committee (15A150015 and 18A150009),
Science & Technology Innovation Talents in Universities of Henan
Province (17HASTIT002), Outstanding Young Talent Cultivation Project
Funding of Henan Normal University (14YR002), and Jilin Province Key
Laboratory of Organic Functional Molecular Design & Synthesis
(130028742).
==== Refs
References
a El-Gamal M. I. ; Abdel-Maksoud M. S. ; El-Din M. M. G. ; Yoo K. H. ; Baek D. ; Oh C.-H. 
Arch.
Pharm. Chem. Life Sci. 
2014 , 347 , 635 10.1002/ardp.201400051 . b Huang H. ; Acquaviva L. ; Berry V. ; Bregman H. ; Chakka N. ; O’Connor A. ; DiMauro E. F. ; Dovey J. ; Epstein O. ; Grubinska B. ; Goldstein J. ; Gunaydin H. ; Hua Z. ; Huang X. ; Huang L. ; Human J. ; Long A. ; Newcomb J. ; Patel V. F. ; Saffran D. ; Serafino R. ; Schneider S. ; Strathdee C. ; Tang J. ; Turci S. ; White R. ; Yu V. ; Zhao H. ; Wilson C. ; Martin M. W. 
ACS Med. Chem. Lett. 
2012 , 3 , 1059 10.1021/ml300278f .24900428  c Caruso M. ; Valsasina B. ; Ballinari D. ; Bertrand J. ; Brasca M. G. ; Caldarelli M. ; Cappella P. ; Fiorentini F. ; Gianellini L. M. ; Scolaro A. ; Beria I. 
Bioorg. Med. Chem. Lett. 
2012 , 22 , 96 10.1016/j.bmcl.2011.11.065 .22154349  d Barf T. ; Kaptein A. ; de Wilde S. ; van der
Heijden R. ; van Someren R. ; Demont D. ; Schultz-Fademrecht C. ; Versteegh J. ; van Zeeland M. ; Seegers N. ; Kazemier B. ; van de Kar B. ; van Hoek M. ; de Roos J. ; Klop H. ; Smeets R. ; Hofstra C. ; Hornberg J. ; Oubrie A. 
Bioorg. Med. Chem.
Lett. 
2011 , 21 , 3818 10.1016/j.bmcl.2011.04.018 .21565500  e Kaptein A. ; Oubrie A. ; de Zwart E. ; Hoogenboom N. ; de Wit J. ; van de Kar B. ; van Hoek M. ; Vogel G. ; de Kimpe V. ; Schultz-Fademrecht C. ; Borsboom J. ; van Zeeland M. ; Versteegh J. ; Kazemier B. ; de Roos J. ; Wijnands F. ; Dulos J. ; Jaeger M. ; Leandro-Garcia P. ; Barf T. 
Bioorg.
Med. Chem. Lett. 
2011 , 21 , 3823 10.1016/j.bmcl.2011.04.016 .21565498 
a Ishii T. ; Shimizu Y. ; Nakashima K. ; Kondo S. ; Ogawa K. ; Sasaki S. ; Matsui H. 
Eur. J. Pharmacol. 
2014 , 723 , 305 10.1016/j.ejphar.2013.11.014 .24291104  b Ohashi T. ; Oguro Y. ; Tanaka T. ; Shiokawa Z. ; Tanaka Y. ; Shibata S. ; Sato Y. ; Yamakawa H. ; Hattori H. ; Yamamoto Y. ; Kondo S. ; Miyamoto M. ; Nishihara M. ; Ishimura Y. ; Tojo H. ; Baba A. ; Sasaki S. 
Bioorg. Med. Chem. 
2012 , 20 , 5507 10.1016/j.bmc.2012.07.034 .22898254 
Anderson D. R. ; Meyers M. J. ; Vernier W. F. ; Mahoney M. W. ; Kurumbail R. G. ; Caspers N. ; Poda G. I. ; Schindler J. F. ; Reitz D. B. ; Mourey R. J. 
J. Med. Chem. 
2007 , 50 , 2647 10.1021/jm0611004 .17480064 
Giblin G. M.
P. ; Billinton A. ; Briggs M. ; Brown A. J. ; Chessell I. P. ; Clayton N. M. ; Eatherton A. J. ; Goldsmith P. ; Haslam C. ; Johnson M. R. ; Mitchell W. L. ; Naylor A. ; Perboni A. ; Slingsby B. P. ; Wilson A. W. 
J. Med. Chem. 
2009 , 52 , 5785 10.1021/jm9009857 .19743867 
a Livecchi M. ; Calvet G. ; Schmidt F. 
J. Org. Chem. 
2012 , 77 , 5006 10.1021/jo300481s .22587741  b Calvet G. ; Livecchi M. ; Schmidt F. 
J. Org. Chem. 
2011 , 76 , 4734 10.1021/jo200480h .21500844  c Tudge M. ; Savarin C. G. ; DiFelice K. ; Maligres P. ; Humphrey G. ; Reamer B. ; Tellers D. M. ; Hughes D. 
Org. Process Res. Dev. 
2010 , 14 , 787 10.1021/op100008m . d Beccalli E. M. ; Broggini G. ; Martinelli M. ; Paladino G. 
Tetrahedron 
2005 , 61 , 1077 10.1016/j.tet.2004.11.066 . e Herz W. ; Tocker S. 
J. Am. Chem. Soc. 
1955 , 77 , 6353 10.1021/ja01628a080 .
a Sun X. ; Wang C. ; Li Z. ; Zhang S. ; Xi Z. 
J. Am.
Chem. Soc. 
2004 , 126 , 7172 10.1021/ja0497173 .15186143  b Zhang Z. ; Zhang F. ; Wang H. ; Wu H. ; Duan X. ; Liu Q. ; Liu T. ; Zhang G. 
Adv. Synth. Catal. 
2015 , 357 , 2681 10.1002/adsc.201500251 .
a Zhang L. ; Zhang Z. ; Liu Q. ; Liu T. ; Zhang G. 
J.
Org. Chem. 
2014 , 79 , 2281 10.1021/jo402773r .24517724  b Zhang Z. ; Zhang L. ; Duan X. ; Yan X. ; Yan Y. ; Liu Q. ; Liu T. ; Zhang G. 
Tetrahedron 
2015 , 71 , 7745 10.1016/j.tet.2015.07.039 .
a Huang P. ; Zhang R. ; Liang Y. ; Dong D. 
Org.
Lett. 
2012 , 14 , 5196 10.1021/ol302314c .23025242  b Mou X.-Q. ; Xu Z.-L. ; Wang S.-H. ; Zhu D.-Y. ; Wang J. ; Bao W. ; Zhou S.-J. ; Yang C. ; Zhang D. 
Chem. Commun. 
2015 , 51 , 12064 10.1039/C5CC03979G . c Shukla G. ; Srivastava A. ; Singh M. S. 
Org. Lett. 
2016 , 18 , 2451 10.1021/acs.orglett.6b00997 .27149251  d Wu L. ; Guo S. ; Wang X. ; Guo Z. ; Yao G. ; Lin Q. ; Wu M. 
Tetrahedron Lett. 
2015 , 56 , 2145 10.1016/j.tetlet.2015.03.019 . e Shankaraiah K. ; Chandrasekhar G. ; Reddy K. S. N. ; Sabitha G. 
Tetrahedron Lett. 
2015 , 56 , 842 10.1016/j.tetlet.2014.12.122 .
a SawpathKumar H. M. ; Subbareddy B. V. ; Anjaneyulu S. ; Yadav J. S. 
Synth. Commun. 
1998 , 28 , 3811 10.1080/00397919808004934 . b Sajiki H. ; Mori A. ; Mizusaki T. ; Ikawa T. ; Maegawa T. ; Hirota K. 
Org. Lett. 
2006 , 8 , 987 10.1021/ol060045q .16494491  c Kour D. ; Khajuria R. ; Kapoor K. K. 
Tetrahedron Lett. 
2016 , 57 , 4464 10.1016/j.tetlet.2016.08.058 .
Fei H. ; Yu J. ; Jiang Y. ; Guo H. ; Cheng J. 
Org. Biomol. Chem. 
2013 , 11 , 7092 10.1039/c3ob41510d .24061209 
Yin Z. ; Zhang Z. ; Kadow J. F. ; Meanwell N. A. ; Wang T. 
J. Org. Chem. 
2004 , 69 , 1364 10.1021/jo030234b .14961693 
Zhang Z. ; Zheng D. ; Ma N. ; Bi J. 
Brønsted Acid-Promoted
the Synthesis of Furo[2,3-b]quinolines . Chin. J. Org. Chem. 
2017 , 37 , 1824 10.6023/cjoc201612032 .
a Zhang Z. ; Qian J. ; Zhang G. ; Ma N. ; Liu Q. ; Liu T. ; Sun K. ; Shi L. 
Org. Chem. Front. 
2016 , 3 , 344 10.1039/C5QO00417A . b Zhang Z. ; Li J. ; Zhang G. ; Ma N. ; Liu Q. ; Liu T. 
J. Org. Chem. 
2015 , 80 , 6875 10.1021/acs.joc.5b00915 .26057737  c Zhang Z. ; Zhang W. ; Li J. ; Liu Q. ; Liu T. ; Zhang G. 
J. Org. Chem. 
2014 , 79 , 11226 10.1021/jo5018487 .25330125  d Zhang Z. ; Tian Q. ; Qian J. ; Liu Q. ; Liu T. ; Shi L. ; Zhang G. 
J. Org. Chem. 
2014 , 79 , 8182 10.1021/jo501385w .25088721  e Qian J. J. ; Zhang Z. G. ; Liu Q. F. ; Liu T. X. ; Zhang G. S. 
Adv. Synth. Catal. 
2014 , 356 , 3119 10.1002/adsc.201400332 . f Zhang Z. ; Wang D. ; Wang B. ; Liu Q. ; Liu T. ; Zhang W. ; Yuan B. ; Zhao Z. ; Han D. ; Zhang G. 
Tetrahedron 
2013 , 69 , 9063 10.1016/j.tet.2013.08.027 .
a Celerier J. P. ; Haddad M. ; Jacoby D. ; Lhommet G. 
Tetrahedron Lett. 
1987 , 28 , 6597 10.1016/S0040-4039(00)96923-5 . b Jacoby D. ; Celerier J. P. ; Haviari G. ; Petit H. ; Lhommet G. 
Synthesis 
1992 , 1992 , 884 10.1055/s-1992-26252 .
Zhang Z. G. ; Ma N.
N. ; Zhang G.
S. ; Liu Q. F. ; Huang Y. Y.  A Kind Method of the Synthesis
of 1H-Pyrrolo[3,2-c]pyridin-4(5H)-ones . China Patent CN 104829614 , 2015 .
Zhang R. ; Liang Y. ; Zhou G. ; Wang K. ; Dong D. 
J. Org. Chem. 
2008 , 73 , 8089 10.1021/jo801289p .18798678 
For more information, please see the SI.


a Yan R. ; Zhou X. ; Li M. ; Li X. ; Kang X. ; Liu X. ; Huo X. ; Huang G. 
RSC Adv. 
2014 , 4 , 50369 10.1039/C4RA10880A . b Chan C.-K. ; Chan Y.-L. ; Chang M.-Y. 
Tetrahedron 
2016 , 72 , 547 10.1016/j.tet.2015.12.021 .
Ichikawa J. ; Wada Y. ; Kuroki H. ; Mihara J. ; Nadano R. 
Org. Biomol. Chem. 
2007 , 5 , 3956 10.1039/b712965c .18043800 
Liu X. ; Zhang N. ; Yang J. ; Liang Y. ; Zhang R. ; Dong D. 
J.
Org. Chem. 
2013 , 78 , 3323 10.1021/jo4001959 .23445321

